AEON Biopharma, Inc. (NYSE AMERICAN: AEON)
$0.1277
+0.0007 ( +0.55% ) 758.8K
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Market Data
Open
$0.1277
Previous close
$0.1270
Volume
758.8K
Market cap
$10.16M
Day range
$0.1210 - $0.1340
52 week range
$0.1210 - $17.1700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |
| 10-q | Quarterly Reports | 77 | Aug 12, 2024 |
| 8-k | 8K-related | 16 | Aug 12, 2024 |
| 10-k/a | Quarterly Reports | 4 | Aug 12, 2024 |
| 8-k | 8K-related | 41 | Aug 06, 2024 |
| 8-k | 8K-related | 14 | Jul 09, 2024 |
| 8-k | 8K-related | 14 | Jun 14, 2024 |
| 3 | Insider transactions | 2 | May 24, 2024 |